Autoinjectors Market

Autoinjectors Market Size by Type (Disposable Autoinjectors and Reusable Autoinjectors), Therapy Area (Anaphylaxis, Rheumatoid Arthritis, Diabetes, Multiple Sclerosis and Others), Route of Administration (Subcutaneous and Intramuscular), End User (Home Care Settings and Hospitals and Clinics), Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2025 to 2034

Base Year: 2024 Historical Data: 2021-23
  • Report ID: TBI-14682
  • Published Date: Mar, 2025
  • Pages: 239
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

Segment Analysis

Regional segmentation analysis

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the most significant global autoinjectors market, with a 37% market revenue share in 2024.

The North American region is leading in autoinjector market operations due to its advanced healthcare infrastructure, substantial healthcare expenditures, and advantageous reimbursement policy structures. The United States, in particular, holds a significant market share due to its well-established healthcare system, robust pharmaceutical industry, and high incidence of chronic diseases. The prevalence of diabetes, rheumatoid arthritis, and allergies throughout the population produces extensive demand for regular injections among patients. The North American population demonstrates a high degree of knowledge about autoinjector products because pharmaceutical companies and healthcare organizations maintain successful marketing and educational outreach activities. Medical insurance coverage for autoinjectors reduces their price, making these devices accessible and affordable to anyone who needs them.

North America Region Autoinjectors Market Share in 2024 - 37%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

  • Meridian Medical Technologies, Kindeva Drug Delivery's global health security division, was awarded a contract worth 129 million to supply DuoDote, a chemical nerve agent antidote autoinjector, to the Strategic National Stockpile (SNS), which the Administration manages for Strategic Preparedness and Response (ASPR) within the United States Department of Health and Human Services. DuoDote is an FDA-approved dual-chamber autoinjector that contains atropine and pralidoxime chloride. It is used to treat poisoning caused by organophosphorus nerve agents and insecticides. Kindeva manufactures DuoDote in the United States and distributes it strategically across the country as part of the country's disaster preparedness program to safeguard citizens from chemical nerve agent attacks.

Type Segment Analysis

The type segment is divided into disposable autoinjectors and reusable autoinjectors. The disposable autoinjectors segment dominated the market, with a market share of around 77% in 2024. The dominance of disposable autoinjectors within the autoinjector market results from their simplified use and enhanced security offerings alongside ready-to-use design. The single-use design of these devices delivers convenient prefilled drug delivery that helps patients get fast, precise and sterile medication injections. The one-time-use design of these devices eliminates maintenance tasks so patients can obtain a clean injection with each use while reducing the likelihood of contamination. These devices feature user-friendly operating systems which users can master without extensive training. The safety features of many disposable autoinjectors include automatic needle retraction and audible or visual warning components that add usability to these devices. Healthcare providers benefit from disposable autoinjectors because supply chains become simpler while avoiding mistakes from incorrect reuse practices. The pharmaceutical industry selects disposable autoinjectors because these devices incorporate prefilled drug syringes to deliver a complete ready-to-use system. Their precise dosing capabilities and sensitivity to contamination make biologics prefer disposable autoinjectors as their go-to device.

  • The FDA has approved Bimzelx 320 mg prefilled syringes and autoinjectors for treating active psoriatic arthritis with concomitant moderate-to-severe plaque psoriasis. The devices will be accessible in the United States during the first quarter of 2025. Bimzelx (bimekizumab-bkzx, UCB) in 160 mg doses is currently available in prefilled syringes and autoinjectors for individuals with moderate to severe plaque psoriasis.

Therapy Area Segment Analysis

The therapy area segment is divided into anaphylaxis, rheumatoid arthritis, diabetes, multiple sclerosis and others. The anaphylaxis segment dominated the market, with a market share of around 35% in 2024. Anaphylaxis represents the main therapy area in the autoinjectors market since epinephrine autoinjectors play a critical role in treating life-threatening allergic reactions. Sudden allergic responses known as anaphylaxis that result from food substances and stinging insects and medications require urgent intervention to prevent devastating consequences. Epinephrine remains the primary treatment, and autoinjectors are the primary reliable device which administrates this lifesaving medication with speed and convenience. The single-use, single-dose format enables both medical and non-medical users to provide the drug rapidly and make correct administrations. The rise in major allergy cases worldwide has triggered the additional market need for anaphylaxis autoinjectors. Device technology improvements, including miniaturized portable designs, have greatly increased the accessibility and usability of these medical devices.

  • LEO Pharma Inc. announced that the Adbry (tralokinumab-ldrm) 300 mg/2 mL single-dose autoinjector was now available in the US. Adbry is now approved in the United States for individuals aged 12 and up with moderate-to-severe atopic dermatitis (AD) whose illness cannot be successfully controlled with topical prescription medications or when those therapies are not recommended. Adbry was previously exclusively available in a 150mg/1mL prefilled syringe. Adult patients now have a more convenient choice with the new 300 mg/2 mL autoinjector device, which requires half the number of injections as the 150 mg/1 mL prefilled syringe.

Route of Administration Segment Analysis

The route of administration segment is divided into subcutaneous and intramuscular. The subcutaneous segment dominated the market, with a market share of around 58% in 2024. The autoinjector market leads with subcutaneous injections because these devices provide convenient self-administration and serve multiple chronic diseases. Subcutaneous medication delivery involves injecting medicine into the fatty tissue under the skin, which demonstrates lower pain and decreased invasiveness than intramuscular or intravenous methods. The subcutaneous route provides an excellent choice for persistent diseases needing consistent injectable medication, which includes diabetes along with rheumatoid arthritis and multiple sclerosis. Subcutaneous injections maintain dominance as the primary administration method because they provide suitable delivery platforms for diverse biological drugs. Subcutaneous administration results in extended medication absorption, which leads to enduring therapeutic outcomes that remain necessary for controlling chronic medical conditions. The automatic needle insertion system, in combination with adjustable dosing and needle retraction functions, lets patients carry out drug delivery operations without requiring medical assistance.

  • Eisai Co. and Biogen Inc. have announced that the US Food and Drug Administration (FDA) has accepted Eisai's Biologics License Application (BLA) for the lecanemab-irmb subcutaneous autoinjector (SC-AI), also known as LEQEMBI in the US. This BLA submission is for weekly maintenance dosage of Alzheimer's disease (AD) in individuals with Mild Cognitive Impairment (MCI) or mild dementia, sometimes known as early AD. The FDA has scheduled a Prescription Drug User Fee Act (PDUFA) action date of August 31, 2025. The BLA submission is based on data from the Clarity AD (Study 301) open-label extension (OLE) and observed data modelling.

End-user Segment Analysis

The end-user segment is divided into home care settings and hospitals and clinics. The home care settings segment dominated the market, with a share of around 67% in 2024. Home care environments deliver impressive economic advantages to public health systems and patients. When patients stay away from hospitals or clinics, they reduce their healthcare spending on transportation costs, doctor fees and in-patient hospital invoices. The dominance of home care settings over the market continues to strengthen as healthcare systems recognize the economic benefits and superior chronic disease management achieved through autoinjectors and home care delivery methods. Home care remains the main end-user segment within the autoinjector market because patients prefer self-administration in their home environment for long-term disease management.

  • Aktiv Medical Systems ('Aktiv'), a US-based medical device technology firm, announced that it has signed a development agreement with a major pharmaceutical company to co-develop a high-concentration, large-dose volume injection medication using its PenPal autoinjector device platform. The medication product features a high-concentration formulation with an injection volume of up to 4 ml. The product will employ a conventional 5.5 ml glass cartridge, allowing for non-standard needle specifications.

Request Table of Content

+1

This study forecasts revenue at global, regional, and country levels from 2021 to 2034. The Brainy Insights has segmented the global autoinjectors market based on below mentioned segments:

Global Autoinjectors Market by Type:

  • Disposable Autoinjectors
  • Reusable Autoinjectors

Global Autoinjectors Market by Therapy Area:

  • Anaphylaxis
  • Rheumatoid Arthritis
  • Diabetes
  • Multiple Sclerosis
  • Others

Global Autoinjectors Market by Route of Administration:

  • Subcutaneous
  • Intramuscular

Global Autoinjectors Market by End User:

  • Home Care Settings
  • Hospitals and Clinics

Global Autoinjectors Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date